Hormones · Aromatization marker

Estradiol(E2)

Estradiol in men comes primarily from aromatization of testosterone in adipose tissue. Both too low and too high impair performance, mood, and cardiovascular health.

Estradiol is the dominant estrogen in reproductive-age women. After menopause, estrone (E1) from adipose aromatization becomes dominant; postmenopausal E2 should be measured by ultra-sensitive LC-MS/MS for accuracy. Oral estrogens dramatically alter SHBG, hepatic clotting factors, and triglycerides.

Optimal range (women)

reproductive · perimenopause · postmenopause

Cycle-dependent. Early follicular (day 2-5): 20-80 pg/mL. Late follicular / pre-ovulatory: 100-400 pg/mL. Mid-luteal: 70-250 pg/mL. Postmenopausal: < 10-20 pg/mL (LC-MS/MS); < 30 pg/mL by immunoassay.pg/mL

Cycle: Strongly cycle-dependent in reproductive-age women — see female_optimal_range_text.

Clinical "normal"

10–40 pg/mL

Avg. cost (US)

$55

Test frequency

With total T, every 3–6 months on TRT

When to measure

Cycling women: cycle day 3 (baseline) or specific cycle phase as clinically indicated. Postmenopausal: any time; use ultra-sensitive (LC-MS/MS) assay.

How to measure

Ultra-sensitive estradiol (LC-MS/MS) — standard E2 assays cross-react with metabolites and overestimate in men.

Average cost

≈ $55 cash price. Often covered by insurance with relevant ICD-10.

Signs your level is off

Symptoms if low

Hot flashes, night sweats, vaginal dryness/atrophy, dyspareunia, mood changes, sleep disturbance, accelerated bone loss, hypoactive sexual desire, brain fog, dry skin.

Symptoms if high

Breast tenderness, fluid retention, headaches/migraines, heavy menses, mood lability, increased thrombotic risk (especially with oral exogenous estrogen). Markedly high E2 may indicate ovarian hyperstimulation, granulosa-cell tumor, or estrogen-producing pathology.

If your level is low

DIM: headaches at high doses

Supplement

Phytoestrogens (soy isoflavones)· 40-80 mg isoflavones/day from food or supplement

Form: food or capsule

Weak SERM-like activity; modest reduction of vasomotor symptoms

Foods

soy (tempeh, edamame, tofu)
flaxseed (lignans)
cruciferous vegetables
adequate dietary fat

Lifestyle

weight maintenance
resistance training (bone protection)
sleep hygiene
stress reduction
layered clothing for vasomotor symptoms

Medication (if prescribed)

Menopausal hormone therapy (transdermal estradiol preferred)· 0.025-0.1 mg/day patch or 0.5-1 mg/day gel; add micronized progesterone 100-200 mg if uterus present

Form: Transdermal patch/gel + oral micronized progesterone

Reference only. Speak with a licensed clinician before any prescription intervention.

Caution: MHT contraindicated in active breast cancer, history of VTE/stroke, active liver disease. Transdermal carries lower VTE risk than oral. Initiate within 10 years of menopause for cardioprotective effect (timing hypothesis).

If your level is high

Anastrozole: bone loss

Supplement

DIM (diindolylmethane) or calcium-D-glucarate· DIM 100-200 mg/day or CDG 500 mg 2-3x/day

Form: capsule

Supports 2-hydroxylation pathway of estrogen metabolism; promotes biliary clearance

Foods

cruciferous vegetables (broccoli, kale, cauliflower)
fiber > 30 g/day
limit alcohol (alcohol raises E2 by 7-20%)

Lifestyle

weight loss if overweight (adipose aromatizes androgens to estrogens)
limit alcohol
reduce xenoestrogen exposure (BPA, phthalates)

Medication (if prescribed)

Address underlying cause· N/A — investigate ovarian/adrenal pathology

Form: N/A

Reference only. Speak with a licensed clinician before any prescription intervention.

Caution: If postmenopausal E2 is elevated without HRT, screen for granulosa-cell tumor, adrenal lesion, or peripheral aromatization. Persistent very high E2 in reproductive-age woman: consider ovarian stimulation, OHSS, or estrogen-producing tumor.

Test these together

These biomarkers contextualize Estradiol and unlock a clearer picture than any single value can.

DHEA-S

Optimal: 300–400 µg/dL

SHBG

Optimal: 15–35 nmol/L

Testosterone Total

Popular

Optimal: 900–1200 ng/dL

Protocols that move this marker

Trt Support

View protocol →

Selected studies

ENDO 2025 PubMed

The prime report

Weekly performance intelligence.

New studies, protocols, and optimization frameworks delivered every Monday. No fluff, no motivation quotes — only what moves the needle.